LOCANABIO INC has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are XIAO WEIDONG, IMGEN CO LTD and APPLIED GENETIC TECHNOLOGIES C.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Singapore | 2 | |
#5 | United States | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Nelles David A | 11 |
#2 | Batra Ranjan | 9 |
#3 | Yeo Eugene | 8 |
#4 | Carter Matthew Merrill | 1 |
#5 | Donohoue Paul Daniel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021007529A1 | Rna-targeting knockdown and replacement compositions and methods for use | |
AU2019326617A1 | FASL immunomodulatory gene therapy compositions and methods for use | |
SG11202012004SA | Rna-targeting fusion protein compositions and methods for use | |
CA3102783A1 | Compositions and methods for the modulation of adaptive immunity |